Amdocs Stock Quote Today

DOX -  USA Stock  

USD 84.91  0.29  0.34%

Market Performance
7 of 100
Odds Of Distress
Less than 9
Amdocs is trading at 84.91 as of the 25th of May 2022; that is 0.34 percent up since the beginning of the trading day. The stock's open price was 84.62. Amdocs has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Amdocs Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of August 2021 and ending today, the 25th of May 2022. Click here to learn more.
Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Chesterfield, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. The company has 124.62 M outstanding shares of which 2.21 M shares are currently shorted by investors with about 3.81 days to cover. More on Amdocs Limited

Amdocs Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Amdocs' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Amdocs or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Over 96.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.marketscreener.com: Telefnica Vivo Expands Long-Term Relationship with Amdocs to Support Their Quad-play Offering - Marketscreener.com
Amdocs Fama & French Business Services
Business Services
Fama & French Classification
Amdocs Limited SEC Filings
Amdocs SEC Filings Security & Exchange Commission EDGAR Reports
CEOEli Gelman  (View All)
Thematic Classifications
Active investing themes Amdocs currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
(view all).
Average Analyst Recommendation
Analysts covering Amdocs report their recommendations after researching Amdocs' financial statements, talking to executives and customers, or listening in on Amdocs' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Amdocs Limited. The Amdocs consensus assessment is calculated by taking the average forecast from all of the analysts covering Amdocs.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Amdocs Limited based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Amdocs Limited financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 5 - HealthyDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares126.6 M118.4 M
Notably Up
Decreasing
Slightly volatile
Weighted Average Shares Diluted148.1 M145.2 M
Fairly Up
Decreasing
Slightly volatile
Net Cash Flow from Operations942.2 M1.1 B
Fairly Down
Increasing
Slightly volatile
Total AssetsB7.5 B
Notably Down
Increasing
Slightly volatile
Total Liabilities2.9 B3.3 B
Fairly Down
Increasing
Slightly volatile
Current Assets1.9 B1.9 B
Slightly Down
Decreasing
Slightly volatile
Current Liabilities1.5 B1.5 B
Slightly Down
Increasing
Slightly volatile
Total Debt1.1 BB
Significantly Up
Increasing
Slightly volatile
Return on Average Assets0.110.12
Significantly Down
Increasing
Slightly volatile
Gross Margin0.310.31
Steady
Decreasing
Slightly volatile
Asset Turnover0.610.58
Sufficiently Up
Decreasing
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Amdocs' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong BuyUndervalued
Financial Strength
Amdocs' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Amdocs' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Amdocs' financial leverage. It provides some insight into what part of Amdocs' total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Amdocs' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Amdocs deploys its capital and how much of that capital is borrowed.
Liquidity
Amdocs cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 879.12 M in debt with debt to equity (D/E) ratio of 0.25, which may show that the company is not taking advantage of profits from borrowing. Amdocs Limited has a current ratio of 1.47, which is typical for the industry and considered as normal. Debt can assist Amdocs until it has trouble settling it off, either with new capital or with free cash flow. So, Amdocs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amdocs Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amdocs to invest in growth at high rates of return. When we think about Amdocs' use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

942.25 MillionShare
Amdocs Limited (DOX) is traded on NASDAQ Exchange in USA. It is located in 1390 Timberlake Manor Parkway and employs 29,000 people. Amdocs is listed under Business Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with total capitalization of 10.34 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amdocs's market, we take the total number of its shares issued and multiply it by Amdocs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Amdocs Limited runs under Technology sector within Software—Infrastructure industry. The entity has 124.62 M outstanding shares of which 2.21 M shares are currently shorted by investors with about 3.81 days to cover. Amdocs Limited has about 868.84 M in cash with 713.44 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.04.
Check Amdocs Probability Of Bankruptcy
Ownership
Amdocs Limited retains a total of 124.62 Million outstanding shares. The majority of Amdocs Limited outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Amdocs Limited to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Amdocs. Please pay attention to any change in the institutional holdings of Amdocs Limited as this could imply that something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check Amdocs Ownership Details

Amdocs Stock Price Odds Analysis

What are Amdocs' target price odds to finish over the current price? Based on a normal probability distribution, the odds of Amdocs jumping above the current price in 90 days from now is under 4%. The Amdocs Limited probability density function shows the probability of Amdocs stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Amdocs has a beta of 0.6022 suggesting as returns on the market go up, Amdocs average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Amdocs Limited will be expected to be much smaller as well. Additionally, the company has an alpha of 0.161, implying that it can generate a 0.16 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 84.91HorizonTargetOdds Above 84.91
96.86%90 days
 84.91 
3.07%
Based on a normal probability distribution, the odds of Amdocs to move above the current price in 90 days from now is under 4 (This Amdocs Limited probability density function shows the probability of Amdocs Stock to fall within a particular range of prices over 90 days) .

Amdocs Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Amdocs that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Amdocs' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Amdocs' value.
InstituionSecurity TypeTotal SharesValue
Fmr LlcCommon Shares15.5 M1.3 B
Janus Henderson Group PlcCommon SharesM571.7 M
View Amdocs Diagnostics

Amdocs Historical Income Statement

Amdocs Limited Income Statement is one of the three primary financial statements used for reporting Amdocs's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Amdocs Limited revenue and expense. Amdocs Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Amdocs Interest Expense is fairly stable at the moment as compared to the past year. Amdocs reported Interest Expense of 12.42 Million in 2021. Weighted Average Shares is likely to rise to about 126.6 M in 2022, whereas Direct Expenses is likely to drop slightly above 2.3 B in 2022. View More Fundamentals

Amdocs Stock Against Markets

Picking the right benchmark for Amdocs stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Amdocs stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Amdocs is critical whether you are bullish or bearish towards Amdocs Limited at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Amdocs without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run CEO Directory Now

   

CEO Directory

Screen CEOs from public companies around the world
All  Next Launch Module

Amdocs Corporate Directors

Amdocs corporate directors refer to members of an Amdocs board of directors. The board of directors generally takes responsibility for the Amdocs' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Amdocs' board members must vote for the resolution. The Amdocs board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Richard LeFave - Independent DirectorProfile
John MacDonald - DirectorProfile
Adrian Gardner - Independent DirectorProfile
Zohar Zisapel - Independent DirectorProfile

Investing Amdocs Limited

You need to understand the risk of investing before taking a position in Amdocs. The danger of trading Amdocs Limited is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Amdocs is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Amdocs. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Amdocs Limited is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Investing Opportunities. Note that the Amdocs Limited information on this page should be used as a complementary analysis to other Amdocs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Amdocs Stock analysis

When running Amdocs Limited price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Amdocs Limited is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine Amdocs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.